LINDAHL RICHARD S (EVP, Chief Financial Officer) reported 1 transaction at EMERGENT BIOSOLUTIONS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/6/2026ACC: 0001196632-26-000009
Officer· EVP, Chief Financial Officer
Since May 2025
+49.21K
Net shares
Net buyer
$199.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
72.86K acquired · 23.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.65K
Price / share
$8.44
Trade value
$199.61K
% of position
9.9%
3/5/2026
239.02K→215.37K
Total
Net shares
−23.65K
Net value
-$199.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | F · Tax Withholding | −23.65K | $8.44 | $199.61K | 9.9% | 239.02K | 215.37K |
| Total | −23.65K | -$199.61K | ||||||
Derivative Transactions1
Employee Stock Option (Right to buy)
Direct
Converts to
Common Stock
72.86K shares
Shares
+72.86K
Strike price
8.99
Held after
557.35K
Exercisable
—
3/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) Direct | Common Stock72.86K shares | 3/3/2026 | A · Award | +72.86K | 8.99 | — | 557.35K |